Cervix Hypoxia FAZA

Status Active, not recruiting

Clinical Trial Summary

The purpose of this study is to look for low levels of oxygen (hypoxia) in your cervix cancer using a special x-ray test called a positron emission tomography (PET)scan. Hypoxia may have an effect on how cervix cancer grows and responds to treatments like radiotherapy and chemotherapy. Doctors at Princess Margaret Hospital have measured hypoxia in over 300 patients. The use of PET scans to measure hypoxia may be better and simpler than the methods used previously.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01549730
Study type	Interventional
Source	University Health Network, Toronto
Contact
Status	Active, not recruiting
Phase	N/A
Start date	May 2011
Completion date	May 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04067882` - Validation of the Genetic Signature 354849 as a Prognostic Method
Completed	`NCT00329589` - A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients	Phase 1
Recruiting	`NCT05743517` - Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)	N/A
Completed	`NCT05234112` - Prevention and Screening Towards Elimination of Cervical Cancer	N/A
Completed	`NCT04258553` - Thiol Disulfide Balance in Cervix Cancer
Completed	`NCT03956498` - Impact of a Sexological Follow-up on the Sexual Function in Patients With Cervix or Vaginal Cancer Treated by Radiotherapy and Brachytherapy	N/A
Active, not recruiting	`NCT04357873` - Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations	Phase 2
Completed	`NCT00379743` - Partnership for Healthy Seniors	N/A
Completed	`NCT00509444` - Cancer Prevention and Treatment Among African American Older Adults: Treatment Trial	Phase 3
Recruiting	`NCT06022029` - A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.	Phase 1
Recruiting	`NCT06116019` - Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)
Completed	`NCT04072913` - Matrix Metalloproteinases and Human Papillomavirus in Dysplasias and Cancers of the Cervix	N/A
Recruiting	`NCT04651127` - Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer	Phase 1/Phase 2
Recruiting	`NCT06010875` - A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors	Phase 1
Completed	`NCT02552121` - Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors	Phase 1/Phase 2
Completed	`NCT02001623` - Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors	Phase 1/Phase 2
Completed	`NCT02997553` - Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery	Phase 3
Terminated	`NCT02233387` - PET CT With HX4 in Cervix Cancer	Phase 2
Completed	`NCT01766284` - Study of the Diagnostic Efficacy of "Real Time" Niris 1300e Optical Coherence Tomography (OCT) Imaging System in the Management of Pre-invasive and Invasive Neoplasia of the Uterine Cervix	N/A
Completed	`NCT00122772` - CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy	Phase 3